fipamezole (BVF 025)
/ Santhera
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 14, 2025
Efficacy and Safety of Twelve Anti-Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
(PubMed, Eur J Neurol)
- "Amantadine ER improved dyskinesia significantly versus amantadine IR. Both formulations of amantadine were superior as OFF time-reducing agents compared to other anti-dyskinetic drugs, whereas amantadine IR non-significantly reduced OFF time versus amantadine ER."
Journal • Retrospective data • Review • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 1
Of
1
Go to page
1